Serum lipoprotein (a) levels in patients with diabetic foot lesions

Diabetes Research and Clinical Practice

Volumn 71, Issue 2, 2006, Pages 119-123

  Ünlühizarci, Kürşad ^a   Muhtaroǧlu, Sabahattin ^a   Kabak, Şevki ^a   Bayram, Fahri ^a   Keleştimur, Fahrettin ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Diabetes mellitus; Foot lesion; Lipoprotein (a)

Indexed keywords

LIPOPROTEIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC FOOT; DIABETIC NEUROPATHY; DISEASE DURATION; FEMALE; GLYCEMIC CONTROL; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; PHYSICAL EXAMINATION; SENSORY NEUROPATHY;

BLOOD GLUCOSE; DIABETIC FOOT; GANGRENE; HUMANS; LIPOPROTEIN(A); REFERENCE VALUES;

EID: 30944442240     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2005.06.005     Document Type: Article

References (30)

1. G.E. Reiber, R.E. Pecoraro, and T.D. Koepsell Risk factors for amputation in patients with diabetes mellitus Ann. Intern. Med. 117 1992 97 105
2. A.L. Calle-Pascual, M.J. Redondo, M. Ballesteros, M.A. Martinez-Salinas, J.A. Diaz, and P. De Matias Nontraumatic lower extremity amputations in diabetic and non-diabetic subjects in Madrid Spain Diab. Metab. 23 1997 519 523
3. A.I. Adler, E.D. Boyko, J.H. Ahroni, and D.G. Smith Lower-extremity amputation in diabetes Diab. Care 22 1999 1029 1035
4. J. Gaubatz, C. Heideman, A.J. Gotto, J. Morisett, and G. Dahlen Human plasma lipoprotein (a). Structural properties J. Biol. Chem. 258 1983 4582 4589
5. J.W. McLean, J.E. Tomlinson, W.J. Kuang, D.L. Eaton, E.Y. Chen, and G.M. Fless cDNA sequence of human apolipoprotein (a) is homologous to plasminogen Nature 330 1987 132 137
6. M. Seed, F. Hoppichler, D. Reavley, S. McCarthy, G.R. Thompson, and E. Boenwinkle Relation of serum lipoprotein (a) concentration and apolipoprotein (a) phenotype to coronary heart disease in patient s with familial hypercholestterolemia N. Engl. J. Med. 322 1990 1494 1499
7. G. Zenker, P. Költringer, B. Gertrude, K. Niederkorn, K. Pfeiffer, and G. Jurgens Lipoprotein (a) as a strong indicator for cerebrovascular disease Stroke 17 1986 942 945
8. R.J. Valentine, P.A. Grayburn, G.L. Vega, and S.M. Grundy Lp (a) lipoprotein is an independent discriminating risk factor for premature peripheral atherosclerosis among white men Arch. Intern. Med. 154 1994 801 806
9. J.H. Calhoun, J. Cantrell, J. Cobos, J. Lacy, R.R. Valdez, and J. Hokanson Treatment of diabetic foot infections: Wagner classification, therapy and outcome Foot Ankle 9 1988 101 106
10. E. Bairaktari, K. Hatzidimou, C. Tzallas, M. Vini, A. Katsaraki, and A. Tselepis Estimation of LDL cholesterol based on the Friedewald formula and on Apo B levels Clin. Chem. 33 2000 549 555
11. M. Sandkamp, H. Funke, H. Schulte, E. Kohler, and G. Assmann Lipoprotein (a) is an independent risk factor for myocardial infarction at a young age Clin. Chem. 36 1990 20 23
12. G.M. Kostner, P. Avogaro, G. Cazzolato, E. Marth, G. Bittolo-Bonn, and G.B. Qunki Lipoprotein Lp (a) and the risk for myocardial infarction Atherosclerosis 38 1981 51 61
13. S.W.K. Cheng, and AC.W. Ting Lipoprotein (a) level and mortality in patients with critical lower limb ischemia Eur. J. Endovasc. Surg. 22 2001 124 129
14. I. Karmansky, and N. Gruener Structure and possible biological roles of Lp (a) Clin. Biochem. 27 1994 151 162
15. M. Alsaeid, M. Qabazard, A. Shaltout, and P.N. Sharma Impact of glycemic control on serum lipoprotein (a) in Arab children with type 1 diabetes Pediatr. Int. 43 2001 246 250
16. L.C. Ramirez, C. Arauz-Pacheco, C. Lackner, G. Albright, B.V. Adams, and P. Raskin Lipoprotein (a) levels in diabetes mellitus: relationship to metabolic control Ann. Int. Med. 117 1992 42 47
17. E. Bruckert, P. Davidoff, A. Grimald, J. Trufifert, P. Giral, and R. Doumith Increased serum levels of lipoprotein (a) in diabetes mellitus and their reduction with glycemic control JAMA 263 1990 35 36
18. M. Torres-Tamayo, L.E. Perez-Pasten, C. Barron-Uribe, I. Hermida-Gutierrez, J. Zamora-Gonzalez, and G. Cardoso-Saldana Improved metabolic control does not change plasma lipoprotein (a) levels in adolescent with type 1 diabetes mellitus Arch. Med. Res. 29 1998 307 312
19. K.H. Song, Y.B. Ahn, K.H. Yoon, B.Y. Cha, K.W. Lee, and H.Y. Son The effect of long-term glycaemic control on serum lipoprotein (a) levels in patients with Type 2 diabetes mellitus Diab. Med. 16 1999 1036 1039
20. G.H. Dahlen, J.R. Guyton, M. Attar, J.A. Fanner, J.A. Kauz, and A.M. Gotto Jr. Association of levels of lipoprotein Lp (a), plasma lipids and other lipoprotein with coronary artery disease documented by angiography Circulation 74 1986 758 765
21. A. Murai, T. Miyahara, N. Fujimoto, M. Matsuda, and M. Kameyama Lp (a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction Atherosclerosis 59 1986 199 206
22. G. Lippi, G.F. Veraldi, V. Dorucci, R. Dusi, O. Ruzzenente, and C. Brentegani Usefulness of lipids, lipoprotein (a) and fibrinogen measurements in identifying subjects at risk of occlusive complications following vascular and endovascular surgery Scand. J. Clin. Lab. Invest. 58 1998 497 504
23. F. Wollesen, G. Dahlen, L. Berglund, and C. Berne Peripheral atherosclerosis and serum lipoprotein (a) in diabetes Diab. Care 22 1999 93 98
24. A. Gaw, and H.H. Hobbs Molecular genetics of lipoprotein (a): new pieces to the puzzle Curr. Opin. Lipidol. 5 1994 149 155
25. K. Matsumoto, S. Mjyake, M. Yano, Y. Ueki, Y. Yamaguchi, and S. Akazawa Insulin resistance and arteriosclerosis obliterans in patients with NIDDM Diab. Care 20 1997 1738 1743
26. T. Gordon, W.B. Kannel, W.P. Castelli, and T.R. Dawber Lipoproteins, cardiovascular disease and death. The Framingham study Arch. Intern. Med. 141 1981 1128 1131
27. G. Assmann, and H. Schulte Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience), Prospective Cardiovascular Munster Study Am. J. Cardiol. 70 1992 733 737
28. A.M. Scanu, and G.M. Fless Lipoprotein (a): heterogenity and biological releavance J. Clin. Invest. 85 1990 1709 1715
29. G. Utermann The mysteries of lipoprotein (a) Science 246 1989 904 910
30. S. Moss, R. Klein, and K. Bek The prevalence and incidence of lower extremity amputation in a diabetic population Arch. Intern. Med. 152 1992 610 616